MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia
Tóm tắt
MAPKAPK-2 (MK2) is a protein kinase activated downstream of p38-MAPK which phosphorylates the small heat shock proteins HSP27 and αB crystallin and modulates p38-MAPK cellular distribution. p38-MAPK activation is thought to contribute to myocardial ischemic injury; therefore, we investigated MK2 effects on ischemic injury and p38 cellular localization using MK2-deficient mice (KO). Immunoblotting of extracts from Langendorff-perfused hearts subjected to aerobic perfusion or global ischemia or reperfusion showed that the total and phosphorylated p38 levels were significantly lower in MK2−/− compared to MK2+/+ hearts at baseline, but the ratio of phosphorylated/total p38 was similar. These results were confirmed by cellular fractionation and immunoblotting for both cytosolic and nuclear compartments. Furthermore, HSP27 and αB crsytallin phosphorylation were reduced to baseline in MK2−/− hearts. On semiquantitative immunofluorescence laser confocal microscopy of hearts during aerobic perfusion, the mean total p38 fluorescence was significantly higher in the nuclear compared to extranuclear (cytoplasmic, sarcomeric, and sarcolemmal compartments) in MK2+/+ hearts. However, although the increase in phosphorylated p38 fluorescence intensity in all compartments following ischemia in MK2+/+ hearts was lost in MK2−/− hearts, it was basally elevated in nuclei of MK2−/− hearts and was similar to that seen during ischemia in MK2+/+ hearts. Despite these differences, similar infarct volumes were recorded in wild-type MK2+/+ and MK2−/− hearts, which were decreased by the p38 inhibitor SB203580 (1 μM) in both genotypes. In conclusion, p38 MAPK-induced myocardial ischemic injury is not modulated by MK2. However, the absence of MK2 perturbs the cellular distribution of p38. The preserved nuclear distribution of active p38 MAPK in MK2−/− hearts and the conserved response to SB203580 suggests that activation of p38 MAPK may contribute to injury independently of MK2.
Tài liệu tham khảo
Armstrong SC, Delacey M, Ganote CE (1999) Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J Mol Cell Cardiol 31(3):555–567 March. doi:10.1006/jmcc.1998.0891
Ballard-Croft C, Kristo G, Yoshimura Y, Reid E, Keith BJ, Mentzer RM Jr, Lasley RD (2005) Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments. Am J Physiol Heart Circ Physiol 288(3):H1359–H1366 March. doi:10.1152/ajpheart.01006.2004
Bassi R, Heads R, Marber MS, Clark JE (2008) Targeting p38-MAPK in the ischaemic heart: kill or cure. Curr Opin Pharmacol 8(2):141–146 February 18
Ben Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ (1998) Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8(19):1049–1057 September 24. doi:10.1016/S0960-9822(98)70442-7
Bluhm WF, Martin JL, Mestril R, Dillmann WH (1998) Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes. Am J Physiol 275(6 Pt 2):H2243–H2249 December
Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben Levy R, Ashworth A, Marshall CJ, Sugden PH (1996) Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79(2):162–173 August
Clark JE, Sarafraz N, Marber MS (2007) Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. Pharmacol Ther 116(2):192–206 November. doi:10.1016/j.pharmthera.2007.06.013
Eaton P, Awad WI, Miller JI, Hearse DJ, Shattock MJ (2000) Ischemic preconditioning: a potential role for constitutive low molecular weight stress protein translocation and phosphorylation? J Mol Cell Cardiol 32(6):961–971 June. doi:10.1006/jmcc.2000.1136
Engel K, Schultz H, Martin F, Kotlyarov A, Plath K, Hahn M, Heinemann U, Gaestel M (1995) Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J Biol Chem 270(45):27213–27221 November 10. doi:10.1074/jbc.270.45.27213
Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, Saklatvala J (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78(6):1039–1049 September 23. doi:10.1016/0092-8674(94)90278-X
Fryer RM, Patel HH, Hsu AK, Gross GJ (2001) Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol 281(3):H1184–H1192 September
Gorog DA, Tanno M, Kabir AM, Kanaganayagam GS, Bassi R, Fisher SG, Marber MS (2003) Varying susceptibility to myocardial infarction among C57BL/6 mice of different genetic background. J Mol Cell Cardiol 35(6):705–708 June. doi:10.1016/S0022-2828(03)00082-8
Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J (1997) Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110(Pt 3):357–368 February
Hollander JM, Martin JL, Belke DD, Scott BT, Swanson E, Krishnamoorthy V, Dillmann WH (2004) Overexpression of wild-type heat shock protein 27 and a nonphosphorylatable heat shock protein 27 mutant protects against ischemia/reperfusion injury in a transgenic mouse model. Circulation 110(23):3544–3552 December 7. doi:10.1161/01.CIR.0000148825.99184.50
Hoover HE, Thuerauf DJ, Martindale JJ, Glembotski CC (2000) alpha B-crystallin gene induction and phosphorylation by MKK6-activated p38. A potential role for alpha B-crystallin as a target of the p38 branch of the cardiac stress response. J Biol Chem 275(31):23825–23833 August 4. doi:10.1074/jbc.M003864200
Huot J, Houle F, Spitz DR, Landry J (1996) HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 56(2):273–279 January 15
Inaguma Y, Ito H, Iwamoto I, Saga S, Kato K (2001) AlphaB-crystallin phosphorylated at Ser-59 is localized in centrosomes and midbodies during mitosis. Eur J Cell Biol 80(12):741–748 December. doi:10.1078/0171-9335-00203
Ito H, Okamoto K, Nakayama H, Isobe T, Kato K (1997) Phosphorylation of alphaB-crystallin in response to various types of stress. J Biol Chem 272(47):29934–29941 November 21. doi:10.1074/jbc.272.47.29934
Ito H, Kamei K, Iwamoto I, Inaguma Y, Nohara D, Kato K (2001) Phosphorylation-induced change of the oligomerization state of alpha B-crystallin. J Biol Chem 276(7):5346–5352 February 16. doi:10.1074/jbc.M009004200
Kato K, Hasegawa K, Goto S, Inaguma Y (1994) Dissociation as a result of phosphorylation of an aggregated form of the small stress protein, hsp27. J Biol Chem 269(15):11274–11278 April 15
Kato K, Ito H, Kamei K, Inaguma Y, Iwamoto I, Saga S (1998) Phosphorylation of alphaB-crystallin in mitotic cells and identification of enzymatic activities responsible for phosphorylation. J Biol Chem 273(43):28346–28354 October 23. doi:10.1074/jbc.273.43.28346
Kato K, Ito H, Iwamoto I, Lida K, Inaguma Y (2001) Protein kinase inhibitors can suppress stress-induced dissociation of Hsp27. Cell Stress Chaperones 6(1):16–20 January. doi:10.1379/1466-1268(2001)006<0016:PKICSS>2.0.CO;2
Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1(2):94–97 June. doi:10.1038/10061
Kotlyarov A, Yannoni Y, Fritz S, Laass K, Telliez JB, Pitman D, Lin LL, Gaestel M (2002) Distinct cellular functions of MK2. Mol Cell Biol 22(13):4827–4835 July. doi:10.1128/MCB.22.13.4827-4835.2002
Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL (1999) Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99(13):1685–1691 April 6
Mackay K, Mochly-Rosen D (1999) An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem 274(10):6272–6279 March 5. doi:10.1074/jbc.274.10.6272
Martin JL, Mestril R, Hilal-Dandan R, Brunton LL, Dillmann WH (1997) Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 96(12):4343–4348 December 16
Martin JL, Hickey E, Weber LA, Dillmann WH, Mestril R (1999) Influence of phosphorylation and oligomerization on the protective role of the small heat shock protein 27 in rat adult cardiomyocytes. Gene Expr 7(4–6):349–355
Martin JL, Avkiran M, Quinlan RA, Cohen P, Marber MS (2001) Antiischemic effects of SB203580 are mediated through the inhibition of p38alpha mitogen-activated protein kinase: Evidence from ectopic expression of an inhibition-resistant kinase. Circ Res 89(9):750–752 October 26. doi:10.1161/hh2101.099504
Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK (1996) Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396(2–3):233–237 November 4. doi:10.1016/0014-5793(96)01109-X
Mehlen P, Hickey E, Weber LA, Arrigo AP (1997) Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells. Biochem Biophys Res Commun 241(1):187–192 December 8. doi:10.1006/bbrc.1997.7635
Mizukami Y, Yoshioka K, Morimoto S, Yoshida K (1997) A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J Biol Chem 272(26):16657–16662 June 27. doi:10.1074/jbc.272.26.16657
Morrison LE, Hoover HE, Thuerauf DJ, Glembotski CC (2003) Mimicking phosphorylation of alphaB-crystallin on serine-59 is necessary and sufficient to provide maximal protection of cardiac myocytes from apoptosis. Circ Res 92(2):203–211 February 7. doi:10.1161/01.RES.0000052989.83995.A5
Preville X, Schultz H, Knauf U, Gaestel M, Arrigo AP (1998) Analysis of the role of Hsp25 phosphorylation reveals the importance of the oligomerization state of this small heat shock protein in its protective function against TNFalpha- and hydrogen peroxide-induced cell death. J Cell Biochem 69(4):436–452 June 15. doi:10.1002/(SICI)1097-4644(19980615)69:4<436::AID-JCB5>3.0.CO;2-O
Ray PS, Martin JL, Swanson EA, Otani H, Dillmann WH, Das DK (2001) Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J 15(2):393–402 February. doi:10.1096/fj.00-0199com
Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78(6):1027–1037 September 23. doi:10.1016/0092-8674(94)90277-1
Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, Marber MS (2000) The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J 14(14):2237–2246 November. doi:10.1096/fj.99-0671com
Saurin A, Pennington D, Raat N, Latchman D, Owen M, Marber M (2002) Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 55(3):672 August 15. doi:10.1016/S0008-6363(02)00325-5
Shiroto K, Otani H, Yamamoto F, Huang CK, Maulik N, Das DK (2005) MK2−/− gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury. J Mol Cell Cardiol 38(1):93–97 January. doi:10.1016/j.yjmcc.2004.10.018
Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M (1992) Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 313(3):307–313 November 30. doi:10.1016/0014-5793(92)81216-9
Tanno M, Bassi R, Gorog DA, Saurin AT, Jiang J, Heads RJ, Martin JL, Davis RJ, Flavell RA, Marber MS (2003) Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation. evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 93(3):254–261
Wang X, Xu L, Wang H, Young PR, Gaestel M, Feuerstein GZ (2002) Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J Biol Chem 277(46):43968–43972 November 15. doi:10.1074/jbc.M206837200
Zu YL, Ai Y, Gilchrist A, Maulik N, Watras J, Sha'afi RI, Das DK, Huang CK (1997) High expression and activation of MAP kinase-activated protein kinase 2 in cardiac muscle cells. J Mol Cell Cardiol 29(8):2159–2168 August. doi:10.1006/jmcc.1997.0449